A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Clinical trial NCT02677896 · COMPLETED
Trial details
- NCT number
- NCT02677896
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-09
- Primary completion
- 2018-10-14
- Enrollment
- 1150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.